Saltar al contenido
Merck

The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF.

The Journal of biological chemistry (2008-11-06)
Sophie Beyer, Malene Maag Kristensen, Kim Steen Jensen, Jens Vilstrup Johansen, Peter Staller
RESUMEN

Posttranslational histone modifications serve to store epigenetic information and control both nucleosome assembly and recruitment of non-histone proteins. Histone methylation occurs on arginine and lysine residues and is involved in the regulation of gene transcription. A dynamic control of these modifications is exerted by histone methyltransferases and the recently discovered histone demethylases. Here we show that the hypoxia-inducible factor HIF-1alpha binds to specific recognition sites in the genes encoding the jumonji family histone demethylases JMJD1A and JMJD2B and induces their expression. Accordingly, hypoxic cells express elevated levels of JMJD1A and JMJD2B mRNA and protein. Furthermore, we find increased expression of JMJD1A and JMJD2B in renal cancer cells that have lost the von Hippel Lindau tumor suppressor protein VHL and therefore display a deregulated expression of hypoxia-inducible factor. Studies on ectopically expressed JMJD1A and JMJD2B indicate that both proteins retain their histone lysine demethylase activity in hypoxia and thereby might impact the hypoxic gene expression program.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Anti-vinculina monoclonal antibody produced in mouse, clone hVIN-1, ascites fluid
Sigma-Aldrich
JMJD2b active human, recombinant, expressed in baculovirus infected Sf9 cells, ≥70% (SDS-PAGE)
Sigma-Aldrich
KDM4DL human, recombinant, expressed in baculovirus infected Sf9 cells, ≥70% (SDS-PAGE)